XMT-1660: A phase 1B trial of a B7-H4 targeting antibody drug conjugate (ADC) in endometrial, ovarian, and breast cancers Meeting Abstract


Authors: Hamilton, E.; Chaudhry, A.; Spira, A.; Adams, S.; Abuhadra, N.; Giordano, A.; Parajuli, R.; Han, H.; Weise, A.; Marchesani, A.; Josephs, K.; Im, E.; Shin, C. R.; Kalinsky, K.
Abstract Title: XMT-1660: A phase 1B trial of a B7-H4 targeting antibody drug conjugate (ADC) in endometrial, ovarian, and breast cancers
Meeting Title: IGCS 2022 Annual Meeting
Journal Title: International Journal of Gynecological Cancer
Volume: 32
Issue: Suppl. 3
Meeting Dates: 2022 Sep 29-Oct 1
Meeting Location: New York, NY
ISSN: 1048-891X
Publisher: Lippincott Williams & Wilkins  
Date Published: 2022-12-01
Start Page: A228
End Page: A229
Language: English
ACCESSION: WOS:000899252300477
DOI: 10.1136/ijgc-2022-igcs.521
PROVIDER: wos
Notes: Meeting Abstract: TP012/#1420 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
Related MSK Work